Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

BioRay Pharmaceutical Co., Ltd.

Clinical trials sponsored by BioRay Pharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New gout pill BR2251 enters Mid-Stage trial Results expected Oct 2026 (estimated)
New antibody drug aims to tackle kidney disease Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 4 Not yet finished but already full! 3 Completed 1 Terminated 4

New cancer drug BR101 enters first human tests

Disease control Completed

This early-phase trial tested a new drug called BR101 in 15 people with advanced solid tumors that had not responded to standard treatments. The main goals were to check the drug's safety, find the right dose, and see if it shows any signs of shrinking tumors. Participants receiv…

Phase 1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 07:58 UTC